<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28832767</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1414-431X</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>17</Day></PubDate></JournalIssue><Title>Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas</Title><ISOAbbreviation>Braz J Med Biol Res</ISOAbbreviation></Journal><ArticleTitle>Antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro.</ArticleTitle><Pagination><StartPage>e6586</StartPage><MedlinePgn>e6586</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e6586</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1414-431X20176586</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0100-879X2017001000602</ELocationID><Abstract><AbstractText>Human enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease (HFMD), particularly in infants and children below 4 years of age. Shikonin is a bioactive compound with anti-inflammatory, antiviral, and antibacterial activities derived from the roots of the Chinese medicinal herb Lithospermum erythrorhizon. This study aimed to examine the antiviral activity of PMM-034, a shikonin ester derivative, against EV71 in rhabdomyosarcoma (RD) cells. Cytotoxicity of PMM-034 on RD cells was determined using WST-1 assay. Dose- and time-dependent effects of PMM-034 on EV71 replication in RD cells were determined using plaque reduction assay. mRNA expression levels of EV71/VP1 and pro-inflammatory cytokines (IL-1&#x3b2;, IL-6, IL-8, and TNF-&#x3b1;) were determined by real-time RT-PCR, and EV71/VP1 and phospho-p65 protein expressions were determined by western blot analysis. PMM-034 exhibited only weak cytotoxicity against RD cells. However, PMM-034 exhibited significant antiviral activity against EV71 in RD cells with 50% inhibitory concentration of 2.31 &#x3bc;g/mL. The VP1 mRNA and protein levels were significantly reduced in cells treated with PMM-034. Furthermore, relative mRNA expression levels of IL-1&#x3b2;, IL-6, IL-8, and TNF-&#x3b1; significantly decreased in the cells treated with PMM-034, while the phospho-p65 protein expression was also significantly lower in the treated cells. These results indicated that PMM-034 suppressed the expressions of pro-inflammatory cytokines in RD cells, exhibiting antiviral activity against EV71, as evidenced by the reduced VP1 mRNA and protein levels in PMM-034-treated cells. Thus, PMM-034 is a promising candidate for further development as an EV71 inhibitor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Suzhou Industrial Park Center for Disease Control and Prevention, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Agriculture, Nanjing Agricultural University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Suzhou Industrial Park Center for Disease Control and Prevention, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Suzhou Industrial Park Center for Disease Control and Prevention, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, NJU-NJFU Joint Institute of Plant Molecular Biology, Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Med Biol Res</MedlineTA><NlmUniqueID>8112917</NlmUniqueID><ISSNLinking>0100-879X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009285">Naphthoquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IK6592UBW</RegistryNumber><NameOfSubstance UI="C016101">shikonin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009285" MajorTopicYN="N">Naphthoquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012208" MajorTopicYN="N">Rhabdomyosarcoma</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28832767</ArticleId><ArticleId IdType="pmc">PMC5561812</ArticleId><ArticleId IdType="doi">10.1590/1414-431X20176586</ArticleId><ArticleId IdType="pii">S0100-879X2017001000602</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen S, Yang Y, Yan X, Chen J, Yu H, Wang W. Influence of vitamin A status on the antiviral immunity of children with hand, foot and mouth disease. Clin Nutr. 2012;31:543&#x2013;548. doi: 10.1016/j.clnu.2011.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2011.12.005</ArticleId><ArticleId IdType="pubmed">22197454</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Ong KC, Gao Z, Zhao X, Anderson VM, McNutt MA, et al. Tonsillar crypt epithelium is an important extra-central nervous system site for viral replication in EV71 encephalomyelitis. Am J Pathol. 2014;184:714&#x2013;720. doi: 10.1016/j.ajpath.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.11.009</ArticleId><ArticleId IdType="pubmed">24378407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu ZL, Xu JL. Research progress on the pathogenesis of EV71-induced neurogenic pulmonary edema. Hn Jornal of Mroology. 2013;1:R725.721.</Citation></Reference><Reference><Citation>Everts M, Cihlar T, Bostwick JR, Whitley RJ. Accelerating drug development: antiviral therapies for emerging viruses as a model. Annu Rev Pharmacol Toxicol. 2017;57:155&#x2013;169. doi: 10.1146/annurev-pharmtox-010716-104533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010716-104533</ArticleId><ArticleId IdType="pubmed">27483339</ArticleId></ArticleIdList></Reference><Reference><Citation>Razonable RR. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc. 2011;86:1009&#x2013;1026. doi: 10.4065/mcp.2011.0309.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2011.0309</ArticleId><ArticleId IdType="pmc">PMC3184032</ArticleId><ArticleId IdType="pubmed">21964179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X, Zhou J, Zhu W, Liu N, Li J, Li L, et al. Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection. BMC Infect Dis. 2012;12:224. doi: 10.1186/1471-2334-12-224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-224</ArticleId><ArticleId IdType="pmc">PMC3519709</ArticleId><ArticleId IdType="pubmed">22994237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Gao L, Jin Y, Cardona CJ, Xing Z. Regulation of host responses and viral replication by the mitogen-activated protein kinases in intestinal epithelial cells infected with Enterovirus 71. Virus Res. 2015;197:75&#x2013;84. doi: 10.1016/j.virusres.2014.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.12.016</ArticleId><ArticleId IdType="pubmed">25529441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Hu YC, Liang CC, Lin SY, Liang YC, Yuan HP, et al. Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling. PLoS One. 2014;9:e111496. doi: 10.1371/journal.pone.0111496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111496</ArticleId><ArticleId IdType="pmc">PMC4216083</ArticleId><ArticleId IdType="pubmed">25360749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh YJ, Yen MH, Chiang YW, Yeh CF, Chiang LC, Shieh DE, et al. Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus-induced cell apoptosis. . J Ethnopharmacol. 2016;185:132&#x2013;139. doi: 10.1016/j.jep.2016.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2016.03.034</ArticleId><ArticleId IdType="pubmed">26993050</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito F, Carli I, Del Vecchio C, Xu L, Corona A, Grandi N, et al. Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication. Phytomedicine. 2016;23:1383&#x2013;1391. doi: 10.1016/j.phymed.2016.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2016.08.001</ArticleId><ArticleId IdType="pubmed">27765358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji P, Chen C, Hu Y, Zhan Z, Pan W, Li R, et al. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease. Biol Pharm Bull. 2015;38:1&#x2013;6. doi: 10.1248/bpb.b14-00357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b14-00357</ArticleId><ArticleId IdType="pubmed">25744451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HY, Chen W, Shi J, Kong WY, Qi JL, Wang XM, et al. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives. Chem Biol Drug Des. 2013;81:275&#x2013;283. doi: 10.1111/cbdd.12077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cbdd.12077</ArticleId><ArticleId IdType="pubmed">23066914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Zhao H, Zhao Z, Yan H, Lv R, Cui L, et al. Rapid screening, identification, and purification of neuraminidase inhibitors from Lithospermum erythrorhizon Sieb.et Zucc. by ultrafiltration with HPLC-ESI-TOF-MS combined with semipreparative HPLC. J Sep Sci. 2016;39:2097&#x2013;2104. doi: 10.1002/jssc.201600087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jssc.201600087</ArticleId><ArticleId IdType="pubmed">27061885</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloch SK, Ma L, Xu GH, Bai LF, Zhao H, Tang CY, et al. A potent anticancer agent of shikonin derivative targeting tubulin. Chirality. 2015;27:274&#x2013;280. doi: 10.1002/chir.22425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chir.22425</ArticleId><ArticleId IdType="pubmed">25663187</ArticleId></ArticleIdList></Reference><Reference><Citation>Andujar I, Rios JL, Giner RM, Recio MC. Pharmacological properties of shikonin - a review of literature since 2002. Planta Med. 2013;79:1685&#x2013;1697. doi: 10.1055/s-0033-1350934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1350934</ArticleId><ArticleId IdType="pubmed">24155261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kourounakis AP, Assimopoulou AN, Papageorgiou VP, Gavalas A, Kourounakis PN. Alkannin and shikonin: effect on free radical processes and on inflammation - a preliminary pharmacochemical investigation. Arch Pharm. 2002;335:262&#x2013;266. doi: 10.1002/1521-4184(200208)335:6&lt;262::AID-ARDP262&gt;3.0.CO;2-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1521-4184(200208)335:6&lt;262::AID-ARDP262&gt;3.0.CO;2-Y</ArticleId><ArticleId IdType="pubmed">12210768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C, et al. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2003;47:2810&#x2013;2816. doi: 10.1128/AAC.47.9.2810-2816.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.47.9.2810-2816.2003</ArticleId><ArticleId IdType="pmc">PMC182643</ArticleId><ArticleId IdType="pubmed">12936978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Yin R, Zhou W, Xu D, Li S. Shikonin and its derivatives: a patent review. Expert Opin Ther Pat. 2012;22:977&#x2013;997. doi: 10.1517/13543776.2012.709237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543776.2012.709237</ArticleId><ArticleId IdType="pubmed">22834677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HY, Li ZK, Bai LF, Baloch SK, Wang F, Qiu HY, et al. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization. Biochem Pharmacol. 2015;96:93&#x2013;106. doi: 10.1016/j.bcp.2015.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2015.04.021</ArticleId><ArticleId IdType="pubmed">25957661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H-Y, Han H-W, Bai L-F, Qiu H-Y, Yin D-Z, Qi J-L, et al. Design, synthesis and biological evaluation of shikonin thio-glycoside derivatives: new anti-tubulin agents. RSC Adv. 2014;4:49796&#x2013;49805. doi: 10.1039/C4RA08810G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4RA08810G</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Qin A, Huang H, Zhou P, Zhang C, Liu N, et al. Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition. Eur J Pharmacol. 2011;658:242&#x2013;247. doi: 10.1016/j.ejphar.2011.02.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.02.043</ArticleId><ArticleId IdType="pmc">PMC3299007</ArticleId><ArticleId IdType="pubmed">21392503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CW, Wu CF, Hsiao NW, Chang CY, Li SW, Wan L, et al. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents. 2008;32:355&#x2013;359. doi: 10.1016/j.ijantimicag.2008.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2008.04.018</ArticleId><ArticleId IdType="pmc">PMC7126984</ArticleId><ArticleId IdType="pubmed">18701259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W, Chiu LC, Ooi VE, Chan PK, Ang PO., Jr Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2. Int J Antimicrob Agents. 2004;24:279&#x2013;283. doi: 10.1016/j.ijantimicag.2004.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2004.02.022</ArticleId><ArticleId IdType="pubmed">15325432</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ooi LS, Wang H, But PP, Ooi VE. Antiviral activities of medicinal herbs traditionally used in southern mainland China. Phytother Res. 2004;18:718&#x2013;722. doi: 10.1002/ptr.1518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.1518</ArticleId><ArticleId IdType="pubmed">15478204</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Peng T. Traditional Chinese herbal medicine as a source of molecules with antiviral activity. Antiviral Res. 2013;97:1&#x2013;9. doi: 10.1016/j.antiviral.2012.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.10.006</ArticleId><ArticleId IdType="pmc">PMC7114103</ArticleId><ArticleId IdType="pubmed">23153834</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhou B, Li C, Chen Q, Wang Y, Li Z, et al. Lariciresinol-4-O-beta-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response. J Ethnopharmacol. 2015;174:379&#x2013;386. doi: 10.1016/j.jep.2015.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2015.08.037</ArticleId><ArticleId IdType="pubmed">26320688</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu Y, Wu T, Jin Y, Cheng J, Wan C, et al. The antiviral effect of baicalin on enterovirus 71 in vitro . Viruses. 2015;7:4756&#x2013;4771. doi: 10.3390/v7082841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082841</ArticleId><ArticleId IdType="pmc">PMC4576202</ArticleId><ArticleId IdType="pubmed">26295407</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Cao RY, Tian X, Yu M, Qin ED, Qin CF. Producing infectious enterovirus type 71 in a rapid strategy. Virol J. 2010;7:116. doi: 10.1186/1743-422X-7-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-116</ArticleId><ArticleId IdType="pmc">PMC2892457</ArticleId><ArticleId IdType="pubmed">20525351</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu Y, Hou X, Peng H, Zhang L, Jiang Q, et al. Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro . PLoS One. 2013;8:e76007. doi: 10.1371/journal.pone.0076007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076007</ArticleId><ArticleId IdType="pmc">PMC3786884</ArticleId><ArticleId IdType="pubmed">24098754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Chen TC, Fang MY, Yen KJ, Shih SR, Hsu JT, et al. Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother. 2010;65:676&#x2013;683. doi: 10.1093/jac/dkp502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp502</ArticleId><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci. 2009;16:103. doi: 10.1186/1423-0127-16-103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-103</ArticleId><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999;73:1941&#x2013;1948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, et al. Production of EV71 vaccine candidates. Hum Vaccin Immunother. 2012;8:1775&#x2013;1783. doi: 10.4161/hv.21739.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.21739</ArticleId><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Weng KF, Shih SR. Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol. 2012;7:467&#x2013;479. doi: 10.2217/fmb.12.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.12.22</ArticleId><ArticleId IdType="pubmed">22439724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye N, Gong X, Pang LL, Gao WJ, Zhang YT, Li XL, et al. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225. doi: 10.1186/s12879-015-0965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0965-1</ArticleId><ArticleId IdType="pmc">PMC4461975</ArticleId><ArticleId IdType="pubmed">26058678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Gao B, Xiong S. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis. Am J Physiol Heart Circ Physiol. 2014;307:H1438&#x2013;H1447. doi: 10.1152/ajpheart.00441.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00441.2014</ArticleId><ArticleId IdType="pubmed">25260607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res. 2003;60:5&#x2013;10. doi: 10.1016/S0008-6363(03)00437-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(03)00437-1</ArticleId><ArticleId IdType="pubmed">14522402</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz ML, Kracht M, Saul VV. The intricate interplay between RNA viruses and NF-kappaB. Biochim Biophys Acta. 2014;1843:2754&#x2013;2764. doi: 10.1016/j.bbamcr.2014.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2014.08.004</ArticleId><ArticleId IdType="pmc">PMC7114235</ArticleId><ArticleId IdType="pubmed">25116307</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol. 2008;82:1787&#x2013;1797. doi: 10.1128/JVI.01798-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, et al. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci. 2000;7:523&#x2013;528. doi: 10.1007/BF02253368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02253368</ArticleId><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>